Trials / Completed
CompletedNCT03090386
Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- —
Summary
This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be administered after treatment of primary brain tumor cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cognitive Surveys | Complete the Cognitive Communication Survey, standardized cognitive and language assessments, and the Follow-up Cognitive Communication Survey after treatment |
Timeline
- Start date
- 2017-02-25
- Primary completion
- 2018-11-15
- Completion
- 2020-11-15
- First posted
- 2017-03-24
- Last updated
- 2020-12-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03090386. Inclusion in this directory is not an endorsement.